Instil Bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 57.07 million compared to USD 54.12 million a year ago. Basic loss per share from continuing operations was USD 8.8 compared to USD 8.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.6 USD | +1.92% | -0.38% | +39.11% |
Apr. 26 | Instil Bio, Inc. Announces Board Changes | CI |
Apr. 15 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.11% | 68.94M | |
+1.51% | 42.75B | |
+47.75% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023